HeyJaredJason Mast
- Indexed articles, last 90 days
- 5
- Latest publication
- Jul 28, 2026
- Outlet visibility, for STAT News
- Top 100K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD (opens the original)
Read excerpt
Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections, arbitration, and a U.S.-China rivalry.
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug (opens the original)
Read excerpt
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another twist for the rare disease drug.
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease (opens the original)
Read excerpt
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an Angelman syndrome medicine.
STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims (opens the original)
Read excerpt
Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular dystrophy and other diseases.
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs (opens the original)
Read excerpt
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For STAT News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.